BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 31038805)

  • 1. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
    World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
    Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
    Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.
    Lee HG; Kim H; Son T; Jeong Y; Kim SU; Dong SM; Park YN; Lee JD; Lee JM; Park JH
    Oncotarget; 2016 Jul; 7(27):41798-41810. PubMed ID: 27260001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
    Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
    Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
    Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma.
    Nishida N; Nishimura T; Nakai T; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Inoue T; Minami Y; Ueshima K; Sakurai T; Kudo M
    Dig Dis; 2014; 32(6):658-63. PubMed ID: 25376281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.
    Jung N; Won JK; Kim BH; Suh KS; Jang JJ; Kang GH
    J Korean Med Sci; 2012 Jun; 27(6):594-604. PubMed ID: 22690089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.